tirzepatide vs compounded semaglutide Troubling Findings in Study of GLP-1 Compounders are all semaglutide the same

Published 2021-5-11 Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD), including atherosclerosis, hypertension and heart failure

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study

A key finding: while 81% of human resource (HR) decision-makers feel that their employees would be interested, only 25% cover GLP-1s today

This list compares their: Medication : Primary Use // Frequency // Starting Dose // Maximum Amount Ozempic: Type 2 Diabetes // Once Weekly // 0.25 mg // 2.0 mg Wegovy : Weight Loss // Once Weekly // 0.25 mg // 2.4 mg up to 7.2 mg* T irzepatide(Mounjaro / Zepbound): Diabetes & Weight Loss // Once Weekly // 2.5 mg // 15.0 mg Retatrutide (Phase 3 Trials): Weight Loss (Investigational) // Once Weekly // 2.0 mg // 12.0 mg Effectivness Comparing data from Retatrutide clinical trials shows it to be significantly more effective for weight loss when compared to previous GLP-1 medications